BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA ...

Revenues of $263.5 million for the quarter ended January 25, 2026; operating earnings of $8.2 million; and net loss from continuing operations of $0.2 million (0.00 $ per share). Subsequent to the ...

March 10, 2026) - Allied Critical Metals Inc. (CSE: ACM) (OTCQB: ACMIF) (FSE: 0VJ0) ("Allied" or the "Company") is pleased to provide additional economic and technical detail from the recently ...

I think really are case studies of Partners Group's value creation efforts at work. Here's a snapshot of the performance fees that we've been able to generate CHF 819 million in performance fees. Most ...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L1 1 /VEGF ...

De Nederlandsche Bank has published its Payment Strategy for 2026–2028, outlining plans to strengthen resilience, broaden payment options, and encourage innovation within the payment system. The ...

Additional Payback Metrics: Payback [1] of approximately 2.2 years from commencement of commercial production corresponding to approximately 4.2 years from start of construction under the medium case ...

After-tax NPV(8%) of $473M (US$346.6M) and 2.2-year payback from start of production with IRR of 48.8% at US$1,000/mtu WO3 Key Highlights: All amounts in Canadian dollars unless stated ...